Jiangsu Recbio Technology Co (HKSE:02179) Net Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Recbio Technology Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Jiangsu Recbio Technology Co's Net Income for the six months ended in Dec. 2024 was HK$-334.45 Mil. Jiangsu Recbio Technology Co's Revenue for the six months ended in Dec. 2024 was HK$0.00 Mil. Therefore, Jiangsu Recbio Technology Co's net margin for the quarter that ended in Dec. 2024 was 0.00%.

The historical rank and industry rank for Jiangsu Recbio Technology Co's Net Margin % or its related term are showing as below:

HKSE:02179's Net Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -107.79
* Ranked among companies with meaningful Net Margin % only.

Jiangsu Recbio Technology Co Net Margin % Historical Data

The historical data trend for Jiangsu Recbio Technology Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Recbio Technology Co Net Margin % Chart

Jiangsu Recbio Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Margin %

Get a 7-Day Free Trial

Jiangsu Recbio Technology Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Margin %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Jiangsu Recbio Technology Co's Net Margin %

For the Biotechnology subindustry, Jiangsu Recbio Technology Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Recbio Technology Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Recbio Technology Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Jiangsu Recbio Technology Co's Net Margin % falls into.

Save Embed

;

Save Embed

;

Jiangsu Recbio Technology Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Jiangsu Recbio Technology Co's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-600.447	/	0
	=	%

Jiangsu Recbio Technology Co's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-334.453	/	0
	=	%

Jiangsu Recbio Technology Co (HKSE:02179) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Jiangsu Recbio Technology Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Jiangsu Recbio Technology Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Recbio Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Recbio Technology Co Ltd (HKSE:02179) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

G93:Germany

Address

No. 888 Yaocheng Avenue, Medical High-tech District, Jiangsu Province, Taizhou, CHN

Website

https://www.recbio.cn

Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.

Executives

Feng Tao	2201 Interest of corporation controlled by you
Bei Jing Jun Lian Cheng Yuan Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Zhu Linan	2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Jun Cheng He Zhong Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Jun Lian Jie You Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Hui Zhi Yi Hao Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Chen Hao	2201 Interest of corporation controlled by you
La Sa Jun Qi Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Shang Hai Chao Rui Yi Yao Ke Ji He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Lyfe Capital Fund Iii (dragon), L.p.
Liu Yong
Chen Wei	2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you

Jiangsu Recbio Technology Co Headlines

No Headlines